Fresenius Medical Care AG (FMS) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Fresenius Medical Care’s revenue went from $17.9B in fiscal 2016 to $23.1B in fiscal 2025, growth of about 2.8% a year.
Net income in fiscal 2025 was $1.1B, a net margin of 5.0%; the best year in this period was 2018 with $2.3B.
Over the twelve months to September 30, 2026, revenue was $21.5B and net income $907M.
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $21.5B | $23.1B | $20.1B | $21.5B | $20.7B | $20.0B | $21.9B | $19.6B | $18.9B | $21.3B | $17.9B |
| Gross profit | — | $5.9B | $4.9B | $5.4B | $5.7B | $5.8B | $6.8B | $6.1B | $5.9B | $7.2B | $5.8B |
| Operating income | — | $2.1B | $1.4B | $1.5B | $1.6B | $2.1B | $2.8B | $2.5B | $3.5B | $2.8B | $2.6B |
| Net income | $907M | $1.1B | $559M | $551M | $718M | $1.1B | $1.4B | $1.3B | $2.3B | $1.5B | $1.2B |
| EPS (diluted) | $1.66 | $2.06 | $1.00 | $0.99 | $1.29 | $1.97 | $2.56 | $2.41 | $4.06 | $2.75 | $2.23 |
| R&D | — | — | — | — | — | — | — | — | — | — | $162M |
| Revenue growth | — | +14.8% | −6.6% | +3.9% | +3.7% | −8.9% | +11.6% | +3.6% | −11.2% | +19.1% | +6.5% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $3.2B | $3.2B | $2.5B | $2.9B | $2.3B | $2.8B | $5.2B | $2.9B | $2.4B | $2.6B | $2.1B |
| Capital spending | -$1.2B | — | — | — | — | — | — | -$1.3B | -$1.2B | -$1.1B | -$1.0B |
| Free cash flow | $2.0B | — | — | — | — | — | — | $1.6B | $1.2B | $1.5B | $1.1B |
| Dividends paid | $441M | $496M | $363M | $363M | $422M | $444M | $431M | $398M | $372M | $353M | $277M |
| Buybacks | — | $688M | — | — | — | — | $449M | $674M | $43M | $69M | $0 |
| Stock-based pay | — | — | — | — | — | — | — | $2M | $12M | $56M | $26M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $1.9B | $1.2B | $1.6B | $1.4B | $1.7B | $1.3B | $1.1B | $2.6B | $1.2B | $747M |
| Debt | — | $12.7B | $11.4B | $13.5B | $14.1B | $15.1B | $15.2B | $15.5B | $8.6B | $8.0B | $8.0B |
| Equity | — | $15.6B | $15.1B | $15.1B | $14.9B | $14.4B | $13.8B | $13.4B | $13.5B | $11.8B | $10.8B |
| Total assets | — | $36.4B | $34.9B | $37.5B | $38.1B | $38.9B | $38.9B | $37.0B | $30.0B | $28.8B | $26.9B |
| Shares (diluted) | 546M | 559M | 559M | 559M | 559M | 559M | 559M | 559M | 559M | 559M | 559M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | 25.6% | 24.6% | 25.3% | 27.4% | 28.8% | 31.0% | 30.9% | 31.1% | 33.8% | 32.3% |
| Operating margin | — | 9.3% | 7.2% | 7.0% | 7.8% | 10.5% | 12.9% | 13.0% | 18.4% | 13.3% | 14.7% |
| Net margin | 4.2% | 5.0% | 2.8% | 2.6% | 3.5% | 5.5% | 6.5% | 6.9% | 12.0% | 7.2% | 6.9% |
| FCF margin | 9.2% | — | — | — | — | — | — | 8.2% | 6.1% | 7.0% | 6.2% |
| ROIC | — | 6.0% | 3.8% | 3.8% | 4.1% | 5.5% | 7.2% | 6.9% | 12.8% | 11.1% | 9.8% |
| ROE | — | 7.3% | 3.7% | 3.7% | 4.8% | 7.6% | 10.4% | 10.0% | 16.9% | 13.0% | 11.5% |
Frequently asked questions
What is Fresenius Medical Care’s annual revenue?
$23.1B in fiscal 2025 and $21.5B over the twelve months to September 30, 2026.
How much profit does Fresenius Medical Care make?
Net income was $1.1B in fiscal 2025 (net margin 5.0%).
Is Fresenius Medical Care’s revenue growing?
Yes: revenue rose 14.8% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.